Table 2.

Antibacterial activity of nanomaterials combined with antibiotics (147).

Nanomaterial	Antibiotics	Target bacteria	References
Ag NPs	Ciprofloxacin Vancomycin Clotrimazole	VRE MRSA MRSA, S. aureus	[145] [146] [147]
Au NPs	Vancomycin Ampicillin	MRSA MRSA, P. aeruginosa, Enterobacter aeruginosa, E. coli	[148] [149]
ZnO NPs	Ciprofloxacin, ceftazidime	MDR A. baumannii	[150]
Fe3O4 NPs	Ampicillin Ampicillin	S. aureus E. coli, P. aeruginosa, MRSA	[151] [152]
CuO NPs	Cephalexin	E. coli	[153]
SWCNTs	Ciprofloxacin	S. aureus, P. aeruginosa, E.coli	[154]
GO	Lincomycin hydrochloride Chloramphenicol Gentamycin sulfate	E. coli, S. aureus	[155]
AMP-NPs	Gentamicin, vancomycin, azithromycin, amoxicillin	S, aureus, E. coli, P. aeruginosa, A. baumanni	[156]
Chitosan	Streptomycin Ciprofloxacin	Listeria monocytogenes Uropathogenic E. coli	[157] [203]